Qingdao Baheal Pharmaceutical Holdings Limited’s Net Profit Rose 91% in First Three Quarters of 2021
Qingdao Baheal Pharmaceutical Holdings Limited (青岛百洋医药股份有限公司) (301015.SZ) reported a net profit of 307.1 million yuan in the first three quarters of 2021, up 91% year-on-year.
Meanwhile, the company posted 5.2 billion yuan in revenue, up 28.4% year-on-year.
At the end of the reporting period, it had 4.7 billion yuan in total assets and 2.5 billion yuan in total liabilities, with a liability-to-asset ratio of 54%.
This article was automatically produced by Caixin Automation on Nov. 3, 2021.
Download our app to receive breaking news alerts and read the news on the go.
Follow the Chinese markets in real time with Caixin Global’s new stock database.
- MOST POPULAR